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AbstrACt
Introduction Randomised controlled trials (RCTs) 
conducted using cohorts and routinely collected health 
data, including registries, electronic health records 
and administrative databases, are increasingly used in 
healthcare intervention research. The development of an 
extension of the CONsolidated Standards of Reporting 
Trials (CONSORT) statement for RCTs using cohorts and 
routinely collected health data is being undertaken with 
the goal of improving reporting quality by setting standards 
early in the process of uptake of these designs. To develop 
this extension to the CONSORT statement, a scoping 
review will be conducted to identify potential modiications 
or clariications of existing reporting guideline items, as 
well as additional items needed for reporting RCTs using 
cohorts and routinely collected health data.
Methods and analysis In separate searches, we will 
seek publications on methods or reporting or that describe 
protocols or results from RCTs using cohorts, registries, 
electronic health records and administrative databases. 
Data sources will include Medline and the Cochrane 
Methodology Register. For each of the four main types of 
RCTs using cohorts and routinely collected health data, 
separately, two investigators will independently review 
included publications to extract potential checklist items. 
A potential item will either modify an existing CONSORT 
2010, Strengthening the Reporting of Observational 
Studies in Epidemiology or REporting of studies Conducted 
using Observational Routinely collected health Data item 
or will be proposed as a new item. Additionally, we will 
identify examples of good reporting in RCTs using cohorts 
and routinely collected health data.
Ethics and dissemination The proposed scoping review 
will help guide the development of the CONSORT extension 
statement for RCTs conducted using cohorts and routinely 
collected health data.
IntroduCtIon 
Randomised controlled trials (RCTs), when 
well designed and conducted, are widely 
acknowledged to be the gold standard for 
evaluating the effectiveness and harms 
of medical interventions.1–3 Important 
concerns exist, however, about many RCTs, 
including limitations related to difficulty 
recruiting sufficiently large and represen-
tative samples, limited real-world generalis-
ability and prohibitive costs.4–12 To attempt 
to address these and other challenges, trial 
designs have been developed in which 
RCTs are conducted within the frameworks 
cohorts4 and routinely collected health 
data. Routinely collected health data are 
defined as data collected for administra-
tive and clinical purposes, without specific 
strengths and limitations of this study
 Ź Our scoping review will be conducted using rigor-
ous methods, with peer-reviewed searches devel-
oped by a research librarian that will comply with 
Institute of Medicine standards and are not limited 
by language.
 Ź Due to the novelty of randomised controlled trials 
using cohorts and routinely collected health data, we 
anticipate identifying only a limited number of meth-
ods and reporting articles in our scoping review.
 Ź To supplement articles on methods and reporting, 
we will review primary trial protocols and reports to 
identify elements that need reporting and to identify 
examples of good reporting.
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a priori research questions,13 and include registries,14 
electronic health records15 and health administrative 
databases.16 
Biomedical research reporting guidelines have been 
developed to assist authors to report research studies 
as accurately, transparently and completely as possible. 
Reporting guidelines typically describe a minimum set 
of information that should be clearly reported, provide 
examples of guideline-consistent reporting and include 
a checklist to facilitate compliance.17 18 Multiple existing 
reporting guidelines include items that are potentially 
applicable to RCTs conducted using cohorts and routinely 
collected health data. In addition to the CONsolidated 
Standards of Reporting Trials (CONSORT) statement for 
reporting of parallel group RCTs,19 reporting guidelines 
with the most direct overlap include the Strengthening 
the Reporting of Observational Studies in Epidemi-
ology (STROBE) guideline for the reporting of observa-
tional studies, generally,20 and the REporting of studies 
Conducted using Observational Routinely collected Data 
(RECORD) guideline21 which address reporting specific 
to observational studies conducted using routinely 
collected health data.
The development of an extension of the CONSORT 
statement for RCTs conducted using cohorts and 
routinely collected health data is being undertaken with 
the goal of improving long-term reporting quality by 
setting standards early in the process of uptake of these 
trial designs.22 To develop this CONSORT extension, 
information is needed to understand which items from 
CONSORT, STROBE and RECORD can be used without 
modification and which should be included with adapta-
tions, as well as aspects of reporting of RCTs conducted 
using cohorts and routinely collected health data that 
are not covered adequately in these reporting guidelines 
and that require new reporting items. In addition, exam-
ples of complete and transparent reporting of different 
aspects of these RCTs are needed.
Relatively little guidance has been published on 
the methods and reporting of RCTs conducted using 
cohorts and routinely collected health data. To account 
for this, the proposed scoping review will identify arti-
cles on the methods or reporting of RCTs conducted 
using cohorts, registries, electronic health records and 
health administrative databases, as well as examples of 
protocols and reports of results from these types of RCTs. 
The objectives of the scoping review are to (1) deter-
mine which items from an initial long list of items based 
on CONSORT, STROBE and RECORD that are being 
considered for possible inclusion in the CONSORT 
extension can be included without modification, iden-
tify items from the initial list that need adaptation and 
identify additional reporting considerations to develop 
new items; and (2) identify examples of complete and 
transparent reporting of different aspects of these types 
of RCTs that can be used to support the CONSORT 
extension.
MEthods
The scoping review will be conducted following the 
approach described by Arksey and O’Malley23 and will be 
reported using the Preferred Reporting Items for System-
atic Reviews and Meta-Analyses: extension for Scoping 
Reviews (PRISMA-ScR) guidelines.24
database searches
In separate searches, we will seek publications that describe 
aspects of methods or reporting or that describe proto-
cols or results from RCTs (including cluster RCTs) using 
(1) cohorts, (2) registries, (3) electronic health records 
and (4) health administrative databases. Ovid MEDLINE 
Epub Ahead of Print, In-Process & Other Non-Indexed 
Citations, Ovid MEDLINE Daily and Ovid MEDLINE and 
EBM Reviews—Cochrane Methodology Registry (Final 
issue, third Quarter 2012) will be searched by an expe-
rienced librarian familiar with knowledge synthesis for 
publications on methods or reporting of these types of 
RCTs and for examples of these types of RCTs. MEDLINE 
strategies for the searches were developed by a research 
librarian with input from the project team and were peer 
reviewed using the Peer Review of the Electronic Search 
Strategy standard.25 The MEDLINE strategy was then 
adapted for the Cochrane Library Methodology Register 
which includes methodological research available up to 
its last update in July 2012.
Search strategies comply with Institute of Medicine 
standards and are not limited by language.26 We will 
search for articles on methods and reporting and exam-
ples of RCTs published in the last 10 years (2008–2018) 
which will allow us to identify relatively recent reporting 
practices and focus on challenging aspects of reporting. 
See online supplementary file 1 for detailed search strat-
egies. In addition to the database searches, references of 
included studies will be reviewed for additional eligible 
studies, a web search will be conducted and members of 
the project team with experience in each type of trial will 
be consulted to provide additional studies that were not 
identified in our search.
study selection
For each search, separately, results will be downloaded 
into the citation management database RefWorks, and 
duplicate references will be removed. Following this, 
references will be transferred into the systematic review 
software DistillerSR (Evidence Partners, Ottawa, Canada). 
A coding manual based on eligibility criteria has been 
developed, and a pilot test of the coding manual will 
be performed prior to the study’s inception. The initial 
coding manuals for inclusion and exclusion for all four 
types of trial designs are shown in online supplementary 
file 2 . Because the trial designs that will be included in 
the CONSORT extension reflect relatively recent devel-
opments, we anticipate that we will identify only a small 
number of articles on their methodology and reporting. 
Thus, we will also include publications of trial protocols 
and results.
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We will assess the eligibility of each publication 
through a two-stage process. In the first stage, two 
reviewers will independently screen titles and abstracts 
to identify potentially relevant studies. We will use 
a liberal accelerated method27 to screen titles and 
abstracts, meaning that articles deemed eligible by one 
of the reviewers will be included in full-text review, and 
only excluded articles will be screened by a second 
reviewer. Since title and abstract screening is done 
randomly and concurrently, reviewers will not know if 
the other reviewer has excluded the reference or not. In 
the second stage, two investigators will independently 
conduct a full-text review. Disagreements after full-
text review will be resolved by consensus, with a third 
investigator consulted as necessary. Translators will be 
consulted to evaluate titles and abstracts and full-text 
articles for languages other than those for which team 
members are fluent, if any. See online supplementary 
file 3 for the preliminary PRISMA flow of studies figures 
for the four types of trial designs.
data extraction and veriication
To develop a preliminary ‘long list’ of items to consider 
for the CONSORT extension checklist, as an initial step, 
items from the CONSORT 2010 will be examined to iden-
tify items where modifications will be needed for RCTs 
conducted using cohorts and routinely collected health 
data, and items from the STROBE and RECORD reporting 
guidelines will be examined to identify additional items 
to complement CONSORT items. Two investigators will 
independently review these reporting guidelines, and any 
item deemed possibly relevant to RCTs using cohorts and 
routinely collected health data by either or both investiga-
tors will be included in the ‘long list’. Additional prelim-
inary ‘long-list’ items will be provided by other members 
of the project team.
For each of the four types of RCTs conducted using 
cohorts and routinely collected health data, separately, 
two investigators will independently review included 
publications to extract additional potential items for the 
‘long list’. A potential item will either modify an existing 
CONSORT 2010, STROBE or RECORD item that has 
been included in the ‘long list’ or will be proposed as a 
new item. Potential items will be identified from publi-
cations that report information relevant to conducting 
RCTs using cohorts and routinely collected health data, 
but that were not included in our initial ‘long list’. In 
addition, potential items will be suggested based on 
gaps in reporting identified from primary trial proto-
cols or reports. Data will be extracted and collected in 
DistillerSR using a standardised data-extraction form. 
The long list of items will evolve dynamically as poten-
tial modifications and new items are added based on 
the review of publications identified from our litera-
ture search using the DistillerSR Dynamic Question 
function. Thus, reviewers will add a potential item only 
once to the long list, after which it becomes visible for 
all reviewers. Reviewers will not duplicate items already 
provided by other reviewers. This will be done to avoid 
redundancy, as we expect potential gaps in reporting 
to occur in multiple publications that will be reviewed. 
In addition to each proposed item modification or 
new item, reviewers will add a brief explanation of 
why the suggested modification or new item is deemed 
important.
In addition to identifying gaps in reporting, for each 
item on our long list, we will attempt to identify exam-
ples of complete and transparent reporting in RCTs using 
cohorts, registries, electronic health record and health 
administrative databases. When examples of complete 
and transparent reporting for a particular item on the 
long list are identified, text corresponding to reporting 
of that item will be inserted in the data-extraction form 
in DistillerSR.
Prior to data extraction from included studies, all 
reviewers will assess a sample of trial reports. The results 
will be compared and discussed among the reviewers in 
order to ensure consistent application of the data-ex-
traction process.
Patient and public involvement
One of the members of our extension to the CONSORT 
statement, Maureen Sauvé, is a patient organisation 
leader. She has been involved in working with researchers 
to establish a cohort of patients living with the rare 
disease, scleroderma, which supports RCTs of trials of 
online rehabilitation, self-management and psychological 
intervention programmes.28
ConClusIon
This scoping review will gather previously published 
methods and recommendations for the reporting of 
RCTs using cohorts and routinely collected health data, 
as well as identify gaps in reporting of these studies. We 
will identify potential modifications or clarifications of 
CONSORT 2010, STROBE and RECORD items, as well 
as potential additional items to develop an extension 
to the CONSORT statement for reporting RCTs using 
cohorts and routinely collected health data. Following 
the scoping review, identified items will be vetted using a 
three-stage Delphi approach29 and a face-to-face meeting, 
after which the reporting checklist and explanation and 
elaboration documents for the CONSORT extension 
will be finalised. The resulting CONSORT extension 
will promote transparency, clarity, reduce research waste 
and provide guidance to researchers on appropriate and 
consistent reporting of RCTs using cohorts and routinely 
collected health data.
EthICs And dIssEMInAtIon
The proposed scoping review will help guide the 
development of the CONSORT extension statement 
for RCTs conducted using cohorts and routinely 
collected health data. The findings will be disseminated 
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through peer-reviewed publications and conference 
presentations.
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